Facultad de Enfermería y Fisioterapia Salus Infirmorum

Bee product efficacy in children with upper respiratory tract infections / (Record no. 13093)

MARC details
000 -LEADER
fixed length control field 02377nas a22002417a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210412134841.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m|||||r|||| 00| 0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field ta
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 171219t2020 sp ||||| |||| 00| 0 spa |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0041-4301
040 ## - CATALOGING SOURCE
Transcribing agency Salus Infirmorum
245 00 - TITLE STATEMENT
Title Bee product efficacy in children with upper respiratory tract infections /
Statement of responsibility, etc. Yılmaz Seçilmiş, Sibel Silici
500 ## - GENERAL NOTE
General note PDF en biblioteca
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Bibliografía: 639-640
520 8# - SUMMARY, ETC.
Summary, etc. Background and objectives. The most common infectious disease in children is acute upper respiratory tract infection (URTI). Many drugs, especially antitussive drugs, are used for symptomatic treatment. Bee products (propolis, royal jelly, and honey) have antiviral, antibacterial, and antioxidant properties, and they have synergistic effects with antibiotics. The aim of this study was to evaluate the effectiveness of a mixture of bee products in URTI in children.<br/>Methods. The patients were divided into four groups consisting of two bacterial groups receiving either antibiotics or antibiotics + bee products and two viral groups treated with either placebo or bee products.<br/>Disease severity and improvement duration were assessed by the Canadian Acute Respiratory Illness and Flu Scale (CARIFS) Score.<br/>Results. One hundred and four patients (59 male, 56.7%; 45 female, 43.3%) aged between 5‒12 years were included in the study. Fifty patients (48%) were evaluated for bacterial infections and 54 (52%) for viral infections. Patients with viral infection receiving a mixture product showed earlier improvement, compared to placebo group. CARIFS scores were significantly lower in antibiotic + mixture group on day-2 and day-4, compared to antibiotic alone group (p <0.05). None of the patients developed any reactions or side effects to the mixture product.<br/>Conclusions. Bee products are effective in symptomatic treatment of upper respiratory tract infections. Bee products can be considered as a good treatment option because the available drugs already used for symptomatic treatment are not cost effective and can also have serious side effects in children.
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term honey
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term propolis
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term royal jelly
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term upper respiratory tract infection
773 ## - HOST ITEM ENTRY
Related parts -- 2020, v. 62, 4, p. 634-640
Title Turkish Journal of Pediatrics
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Universal Decimal Classification
Koha item type Artículo de revista
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Universal Decimal Classification     Non-fiction Revistas y artículos Revistas y artículos 12/04/2021   PP 5736 12/04/2021 12/04/2021 Artículo de revista

Powered by Koha